JP2024524526A5 - - Google Patents

Info

Publication number
JP2024524526A5
JP2024524526A5 JP2024500087A JP2024500087A JP2024524526A5 JP 2024524526 A5 JP2024524526 A5 JP 2024524526A5 JP 2024500087 A JP2024500087 A JP 2024500087A JP 2024500087 A JP2024500087 A JP 2024500087A JP 2024524526 A5 JP2024524526 A5 JP 2024524526A5
Authority
JP
Japan
Prior art keywords
cytosine
st6galnac5
seq
position corresponding
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024500087A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024524526A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/035741 external-priority patent/WO2023278713A1/en
Publication of JP2024524526A publication Critical patent/JP2024524526A/ja
Publication of JP2024524526A5 publication Critical patent/JP2024524526A5/ja
Pending legal-status Critical Current

Links

JP2024500087A 2021-07-02 2022-06-30 α-N-アセチルガラクトサミニドα-2,6-シアリルトランスフェラーゼ5(ST6GALNAC5)阻害剤による認知障害の治療 Pending JP2024524526A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163217937P 2021-07-02 2021-07-02
US63/217,937 2021-07-02
PCT/US2022/035741 WO2023278713A1 (en) 2021-07-02 2022-06-30 Treatment of cognitive impairment with alpha-n-acetylgalactosaminide alpha-2,6-sialyltransferase 5 (st6galnac5) inhibitors

Publications (2)

Publication Number Publication Date
JP2024524526A JP2024524526A (ja) 2024-07-05
JP2024524526A5 true JP2024524526A5 (cg-RX-API-DMAC7.html) 2025-07-03

Family

ID=82742788

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024500087A Pending JP2024524526A (ja) 2021-07-02 2022-06-30 α-N-アセチルガラクトサミニドα-2,6-シアリルトランスフェラーゼ5(ST6GALNAC5)阻害剤による認知障害の治療

Country Status (9)

Country Link
US (1) US20230034093A1 (cg-RX-API-DMAC7.html)
EP (1) EP4363582A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024524526A (cg-RX-API-DMAC7.html)
KR (1) KR20240042611A (cg-RX-API-DMAC7.html)
CN (1) CN117836411A (cg-RX-API-DMAC7.html)
AU (1) AU2022300980A1 (cg-RX-API-DMAC7.html)
CA (1) CA3223334A1 (cg-RX-API-DMAC7.html)
IL (1) IL309386A (cg-RX-API-DMAC7.html)
WO (1) WO2023278713A1 (cg-RX-API-DMAC7.html)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100029748A1 (en) * 2008-08-04 2010-02-04 Sloan-Kettering Institute For Cancer Research Metastasis Promoting Genes and Proteins

Similar Documents

Publication Publication Date Title
Nakamori et al. A slipped-CAG DNA-binding small molecule induces trinucleotide-repeat contractions in vivo
Sabirzhanov et al. Downregulation of miR-23a and miR-27a following experimental traumatic brain injury induces neuronal cell death through activation of proapoptotic Bcl-2 proteins
George et al. Adenosine deaminases acting on RNA, RNA editing, and interferon action
WO2018175502A2 (en) Treating cancer with cas endonuclease complexes
Toonen et al. Intracerebroventricular administration of a 2′-O-methyl phosphorothioate antisense oligonucleotide results in activation of the innate immune system in mouse brain
US20190010548A1 (en) Methods and materials for determining pain sensitivity and predicting and treating related disorders
JP2022523301A5 (cg-RX-API-DMAC7.html)
Branford et al. A novel BCR–ABL transcript (e8a2) with the insertion of an inverted sequence of ABL intron 1b in a patient with Philadelphia‐positive chronic myeloid leukaemia
WO2021107005A1 (ja) サイトメガロウイルス関連疾患の予防又は治療用の剤
US20250332231A1 (en) Treating cancer with cas endonuclease complexes
Iwaki et al. Accumulation of αB-crystallin in brains of patients with Alexander's disease is not due to an abnormality of the 5′-flanking and coding sequence of the genomic DNA
IE920229A1 (en) Regulation of nucleic acid translation
KR930701180A (ko) 올리고 뉴클레오티드에 의한 세포 유착의 조절
KR101783444B1 (ko) miR-33-5p 를 이용한 뇌신경세포 보호 물질 스크리닝 방법
Zhang et al. The proline-rich acidic protein is epigenetically regulated and inhibits growth of cancer cell lines
Hernández-Rivera et al. NRAMP1 polymorphisms like susceptibility marker in Mexican focus of cutaneous leishmaniasis
JP2022525545A5 (cg-RX-API-DMAC7.html)
CA3237033A1 (en) Methods of treating headaches and migraines with sodium voltage-gated channel alpha subunit 11 (scn11a) inhibitors
JP2024524375A5 (cg-RX-API-DMAC7.html)
JP2024529400A5 (cg-RX-API-DMAC7.html)
KR20010072475A (ko) 재발협착증을 치료하기 위한 dna자임 및 치료 방법
JP2022525546A5 (cg-RX-API-DMAC7.html)
Kegelmeyer et al. Differential display identified changes in mRNA levels in regenerating livers from chloroform‐treated mice
Bazick et al. Nickase NmCas9 unsilences paternal Ube3a in a mouse model of Angelman syndrome without causing AAV vector integration
JP2024535110A5 (cg-RX-API-DMAC7.html)